CureMatch Joins CancerX to Help Advance Innovative Cancer Treatments
CureMatch, Inc., a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision medicine support for oncology, today announced that the organization has become a proud member of CancerX. CancerX is a public-private partnership launched by The White House, which aims to be a national accelerator boosting innovation in the fight against cancer as part of the reignited Cancer Moonshot initiative.